Genome-wide
association studies (GWAS) have proven to be a powerful approach to discovering genes
Abstract: Over fifteen years, genome-wide
association studies (GWAS) have identified several
Kazantseva, A.V.,
Davydova, Yu. D.,
Enikeeva, R.F.,
Takhirova, Z.R.,
Mustafin, R.N.,
Lobaskova, M.M.,
Malykh, S.B.,
Khusnutdinova, E.K. (2023) Abstract: A large number of genome-wide
association studies (GWASs) of cognitive abilities (i
Nasyrova, Regina F,
Vaiman, Elena E,
Repkina, Vera V,
Khasanova, Aiperi K,
Asadullin, Azat R,
Shipulin, German A,
Altynbekov, Kuanysh S,
Al-Zamil, Mustafa,
Petrova, Marina M,
Shnayder, Natalia A (2023) was to review the results of
associative genetic and genome-wide
studies and to systematize and update
Nurgalieva, A.Kh.,
Bashkatov, S.A.,
Volkova, E.V.,
Petrova, S.G.,
Takhirova, Z.R.,
Mustafin, R.N.,
Fedorova, Y.Y.,
Prokofyeva, D.S.,
Khusnutdinova, E.K. (2023) of future endeavors. There has been conducted a molecular genetic
study of the frequency distribution
Kazantseva, A.,
Enikeeva, R.,
Takhirova, Z.,
Davydova, Y.,
Mustafin, R.,
Malykh, S.,
Karunas, A.,
Kanapin, A.,
Khusnutdinova, E. (2023) To date, multiple efforts have been made to use genome-wide
association studies (GWAS) to untangle
Timasheva, Y.,
Balkhiyarova, Z.,
Avzaletdinova, D.,
Rassoleeva, I.,
Morugova, T.V.,
Korytina, G.,
Prokopenko, I.,
Kochetova, O. (2023) We tested
associations between 13 established genetic variants and type 2 diabetes (T2D) in 1371
Objectives. To
study predictors of adverse outcomes in ischemic stroke
associated with COVID-19